Eliem Therapeutics Stock Target Price and Analyst Consensus
| ELYMDelisted Stock | USD 3.04 0.19 5.88% |
The current analyst and expert consensus on Eliem Therapeutics is Strong Sell, with no strong buy opinions. The current projected Eliem Therapeutics target price consensus is 4.50 with 0 analyst opinions. Check out Macroaxis Advice on Eliem Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Eliem Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Eliem Therapeutics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Eliem Therapeutics. We encourage you to use your own analysis of Eliem Therapeutics to validate this buy or sell advice. Eliem Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Eliem Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 4.9059.
Lowest Forecast 4.1 | Highest Forecast 5 | Target Price 4.5 |
Eliem |
It's important to approach Eliem Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Eliem Therapeutics Analyst Ratings
Eliem Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Eliem Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Eliem Therapeutics' financials, market performance, and future outlook by experienced professionals. Eliem Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Eliem Therapeutics price targets
Eliem Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Eliem Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Eliem Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Eliem Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Eliem Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Eliem Therapeutics is a key component of Eliem Therapeutics valuation and have some predictive power on the future returns of a Eliem Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eliem Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested few shares | |
 | Online Gaming Invested few shares | |
 | Disruptive Technologies Invested one share | |
 | Mid Cap ETFs Invested few shares | |
 | Alternative Energy Invested over 20 shares | |
 | Artificial Intelligence Invested one share | |
 | ESG Investing Invested few shares | |
 | Rentals Invested one share | |
 | Impulse Invested few shares | |
 | Investor Favorites Invested over 200 shares |
Check out Macroaxis Advice on Eliem Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Eliem Stock
If you are still planning to invest in Eliem Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eliem Therapeutics' history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |